APOP News and Press, Cellect Biotechnology Ltd. From 09/15/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re jumping back into the stock market as we take a look at the biggest pre-market stock movers for Wednesday. Source: f11photo/Shutterstock.com We’ve got loads of stocks to t...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. The stock market closed the week on a relatively risk-off environment even with a much worse-than-expected number of jobs added to the econom...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ Cellect Biotechnology Ltd. Announces First ApoGraft Transplantation in U.S. Patient ” Cellect Biotechnology Ltd. (NASDAQ: APOP) surged over 61% in pre...

Gainers: Cellect Biotechnology (NASDAQ:APOP) +29%. Katapult (NASDAQ:KPLT) +27%. Innate Pharma (NASDAQ:IPHA) +25%. MongoDB  (NASDAQ:MDB) +24%. Draganfly (NASDAQ:DPRO) +22%. Future FinTech (NASDAQ:FTFT) +18%. Neonode (NASDAQ:NEON) +18%. Impel NeuroPharma (NASDAQ:IMPL) +15%. The L.S. Starre...

Shares of Cellect Biotechnology Ltd. (NASDAQ:APOP) traded today at $8.88, eclipsing its 52-week high. This new high was reached on above average trading volume as 10.3 million shares traded hands, while the average 30-day volume is approximately 855,000 shares. Cellect Biotechnology Ltd ...

Gainers: Cellect Biotechnology (NASDAQ:APOP) +39%. NeuroOne Medical Technologies (NASDAQ:NMTC) +17%. Enveric Biosciences (NASDAQ:ENVB) +16%. Impel NeuroPharma (NASDAQ:IMPL) +12%. Progenity (NASDAQ:PROG) +10%. Losers: Forte Biosciences (NASDAQ:FBRX) -81%. Evelo Biosciences (NASDAQ:EV...

Cellect Biotechnology (NASDAQ:APOP) +69% after reporting first ApoGraft Bone Marrow Transplantation in U.S. PagerDuty (NYSE:PD) +15% on Q2 earnings. Enveric Biosciences (NASDAQ:ENVB) +15%. MongoDB (NASDAQ:MDB) +14%. Sinopec Shanghai Petrochemical (NYSE:SHI) +13%. The OLB (NASDAQ:OLB...

 Tel Aviv, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Reflecting continued clinical progress, Cellect Biotechnology Ltd. (NASDAQ: “APOP”), announced the first ApoGraft TM transplantation in a Leukemia patient in the Company’s clinical trial at Washington Uni...

Strategic Merger Transaction Remains on Track to Close During the 2021 Third Quarter Tel Aviv, Israel, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology that enables the functional selection of stem cells, today r...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! It’s been a while but we’re back at it with a look at the biggest pre-market stock movers for Monday. Source: f11photo/Shutterstock.com But before that, take a quick second to c...